Inventor · disambiguated record
John Mattila
Also filed as: MATTILA JOHN
10 granted patents·18 pending applications·57 citations·filing 2015–2025
85Inventor score
Top patents by PatentIndex Score
28 records- 0195US10342876B2Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2015·Granted Jul 9, 2019·17 cites·21 claims
- 0294US10626142B2Purification platform for bispecific antibodiesREGENERON PHARMA·Filed 2015·Granted Apr 21, 2020·34 cites·40 claims
- 0392US11333642B2Methods and systems for chromatography data analysisREGENERON PHARMA·Filed 2020·Granted May 17, 2022·3 cites·20 claims
- 0488US10613063B2Methods and systems for chromatography data analysisREGENERON PHARMA·Filed 2017·Granted Apr 7, 2020·3 cites·21 claims
- 0584US2024415969A1Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0682US2023348532A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0782US2023331776A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0882US2023332084A1Bioreactor for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0982US2023287043A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1082US2023332201A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1182US2024010737A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1280US2023273163A1Methods and systems for chromatography data analysisREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1380US2025281618A1Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1478US11680930B2Methods and systems for chromatography data analysisREGENERON PHARMA·Filed 2022·Granted Jun 20, 2023·0 cites·20 claims
- 1574US2025326786A1Systems and methods for preparing a polypeptide from a mixtureREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1673US12070502B2Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2019·Granted Aug 27, 2024·0 cites·48 claims
- 1771US2025161457A1Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1870US2024209021A1Systems and methods for preparing a polypeptide from a mixtureREGENERON PHARMACEUTICALS INS·Filed 2023·Application pending·0 cites
- 1965US2025214062A1Systems and methods for chromatography use and regenerationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 2064US12246305B2Systems and methods for chromatography use and regenerationREGENERON PHARMA·Filed 2020·Granted Mar 11, 2025·0 cites·24 claims
- 2164US2024384243A1Viral clearance by low ph holdREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2263US12234277B2Hydrophobic interaction chromatography for viral clearanceREGENERON PHARMA·Filed 2021·Granted Feb 25, 2025·0 cites·24 claims
- 2362US11884698B2Systems and methods for preparing a polypeptide from a mixtureREGENERON PHARMA·Filed 2019·Granted Jan 30, 2024·0 cites·11 claims
- 2462US2025095773A1Methods and systems for developing chromatography protocolsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2561US2025163134A1Hydrophobic interaction chromatography for viral clearanceREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 2658US2024199688A1Methods for reducing lipase activityREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2757US12077782B2Viral clearance by low pH holdREGENERON PHARMA·Filed 2021·Granted Sep 3, 2024·0 cites·38 claims
- 2841US2022259261A1Method for viral inactivationREGENERON PHARMA·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →